-
Foregone Net Monetary Benefit From Underdiagnosis and Undertreatment of Mild Cognitive Impairment Due to Alzheimer’s Disease in the Medicare Population
Sep 9, 2025, 16:22 PM -
Healthcare Burden Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Common Criticism of Patient-Reported Outcomes (PRO) in Health Technology Assessments (HTA) by the Institute for Quality and Efficiency in Healthcare (IQWiG) in Breast Cancer and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Eliciting Patients' and Clinicians' Preferences on Adjuvant Treatment for HR+/HER2- Early Breast Cancer: Design of a Probabilistic Threshold Technique in Italy
Sep 9, 2025, 16:22 PM -
Facilitating Investment in Obesity Care and Prevention: A Societal Cost Benefit Analysis for the Netherlands
Sep 9, 2025, 16:22 PM -
Real-World Cancer Treatments for Common Solid Tumors in China: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Addressing the Inherent Challenges of the French National Claims Database (SNDS) Through Algorithms to Identify Patients With Diffuse Large B-cell Lymphoma (DLBCL) and Their Chemotherapy Treatments
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis With Subgroup Analyses by Population Type
Sep 9, 2025, 16:22 PM -
Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo
Sep 9, 2025, 16:22 PM -
Assessing the Value of Purewick™ System for the Management of Female Patients With Urinary Incontinence in the Nonacute Setting: Preliminary Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Estimation of the Prevalent Presymptomatic Type 1 Diabetes Population in Germany Using a Patient Funnel Model
Sep 9, 2025, 16:22 PM -
Real-World Differences in Breast Cancer Management by Detection Method: A Czech National Analysis
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)
Sep 9, 2025, 16:22 PM -
NICE Technology Appraisal Submissions for Non-Small Cell Lung Cancer: Analysis and Insights
Sep 9, 2025, 16:22 PM -
Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data
Sep 9, 2025, 16:22 PM -
Treatments for Children With Newly Diagnosed Medulloblastoma: A Systematic Review Of Randomized Controlled Trials
Sep 9, 2025, 16:22 PM -
How the NHS Can Optimize Health Outcomes in a Time of Financial Constraint
Sep 9, 2025, 16:22 PM
